| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 94.02M | AU$ 95.02M | AU$ 88.18M | AU$ 78.32M | AU$ 65.72M |
| Gross Profit | AU$ 78.21M | AU$ 79.14M | AU$ 80.45M | AU$ 50.59M | AU$ 46.62M |
| Operating Income | AU$ 40.53M | AU$ 45.73M | AU$ 48.01M | AU$ 40.91M | AU$ 33.08M |
| EBITDA | AU$ 41.11M | AU$ 57.20M | AU$ 56.28M | AU$ 46.37M | AU$ 35.08M |
| Net Income | AU$ 33.92M | AU$ 36.17M | AU$ 35.64M | AU$ 30.60M | AU$ 20.88M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 252.06M | AU$ 224.11M | AU$ 183.87M | AU$ 156.81M | AU$ 121.51M |
| Total Assets | AU$ 296.15M | AU$ 271.75M | AU$ 231.12M | AU$ 194.52M | AU$ 144.81M |
| Total Debt | AU$ 1.94M | AU$ 528.53K | AU$ 879.78K | AU$ 999.87K | AU$ 1.26M |
| Net Debt | AU$ -18.49M | AU$ -223.58M | AU$ -182.99M | AU$ -22.87M | AU$ -26.15M |
| Total Liabilities | AU$ 23.27M | AU$ 30.94M | AU$ 28.11M | AU$ 29.89M | AU$ 19.25M |
| Stockholders' Equity | AU$ 272.88M | AU$ 240.81M | AU$ 203.01M | AU$ 164.63M | AU$ 125.56M |
| Cash Flow | |||||
| Free Cash Flow | AU$ 35.31M | AU$ 40.80M | AU$ 31.48M | AU$ 35.88M | AU$ 39.44M |
| Operating Cash Flow | AU$ 36.91M | AU$ 41.10M | AU$ 37.05M | AU$ 36.91M | AU$ 39.87M |
| Investing Cash Flow | AU$ -39.12M | AU$ -47.72M | AU$ -29.03M | AU$ -1.03M | AU$ -434.44K |
| Financing Cash Flow | AU$ -2.75M | AU$ -2.94M | AU$ -3.57M | AU$ -2.24M | AU$ -1.50M |
Clinuvel Pharmaceuticals Limited (DE:UR9)
FRANKFURT:UR9
